2 REIMAGINE 3 was a 40-week phase 3 trial evaluating the safety and efficacy of CagriSema 2.4 mg/2.4 mg and 1 mg/1 mg once weekly versus dose-matched placebo in 274 adults with T2D as add-on to once-daily basal insulin with or without metformin
Ayn zamanda mide boalmasnn yavalamas sayesinde tokluk hissi daha uzun srer
Possible Complications When Diagnosed with Rhabdomyolysis Common Complications and Risks: Sudden kidney damage or failure Imbalances of electrolytes, minerals needed for bodily functions Irregular heartbeat Increased pressure within a muscle compartment that compromises blood flow A condition causing blood clots to form throughout the bodys small blood vessels Severe kidney disease that requires dialysis or transplant Infections due to an extended stay in the hospital Recovery from Rhabdomyolysis Individuals who have survived traumatic rhabdomyolysis, a condition where a large amount of muscle breakdown occurs, may need surgeries related to the bone (orthopedic) or blood vessels (vascular)
Age, weight, and comorbid conditions impact pharmaceutical pharmacokinetics, glycemic management, and operative risk
This type of medication behaves similarly to natural GLP-1 hormones in the body by promoting the production of insulin by the pancreas, supporting a sense of satiety while also slowing the movement of food along the digestive tract and by inhibiting the secretion of glucagon as food is digested
4 PfefferMAClaggettBDiazRDicksteinKGersteinHCKberLVet al